BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3909540)

  • 1. Comparison of two immuno-mechanical methods of T-cell depletion of human bone-marrow for prevention of graft-versus-host disease: soybean lectin agglutination and sheep erythrocyte rosette depletion versus triple rosette depletion.
    Woolfrey AE; Neudorf S; Filipovich AH
    Thymus; 1985; 7(6):327-34. PubMed ID: 3909540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of three techniques for the ex vivo elimination of T cells from human bone marrow.
    Blazar BR; Quinones RR; Heinitz KJ; Sevenich EA; Filipovich AH
    Exp Hematol; 1985 Feb; 13(2):123-8. PubMed ID: 3882442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell depletion from human bone marrow using magnetic beads.
    Knobloch C; Spadinger U; Rueber E; Friedrich W
    Bone Marrow Transplant; 1990 Jul; 6(1):21-4. PubMed ID: 2390629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific ex-vivo depletion of human bone marrow T lymphocytes by an anti-pan-T cell (CD5) ricin A-chain immunotoxin.
    Siena S; Villa S; Bonadonna G; Bregni M; Gianni AM
    Transplantation; 1987 Mar; 43(3):421-6. PubMed ID: 3103275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cellular sorting methods in autologous (elimination of residual malignant cells) or allogeneic (T lymphocyte elimination) bone marrow grafts. Clinical pilot studies].
    Hervé P; Flesch M
    Nouv Rev Fr Hematol (1978); 1986; 28(2):97-105. PubMed ID: 2942838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation of HLA-mismatched marrow depleted of T-cells by lectin agglutination and E-rosette depletion.
    O'Reilly RJ; Collins N; Dinsmore R; Kernan N; Siena S; Brochstein J; Kirkpatrick D; Flomenberg N; Shank B; Dupont B
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):99-107. PubMed ID: 3914748
    [No Abstract]   [Full Text] [Related]  

  • 7. HLA nonidentical T cell depleted marrow transplants: a comparison of results in patients treated for leukemia and severe combined immunodeficiency disease.
    O'Reilly RJ; Keever C; Kernan NA; Brochstein J; Collins N; Flomenberg N; Laver J; Emanuel D; Dupont B; Cunningham I
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):55-60. PubMed ID: 3321647
    [No Abstract]   [Full Text] [Related]  

  • 8. T-cell depletion and allogeneic bone marrow transplantation.
    O'Reilly RJ
    Semin Hematol; 1992 Apr; 29(2 Suppl 1):20-6. PubMed ID: 1615341
    [No Abstract]   [Full Text] [Related]  

  • 9. Enrichment for GM-CFU from human bone marrow using Sambucus nigra agglutinin: potential application to bone marrow transplantation.
    Mumcuoglu M; Manor D; Slavin S
    Exp Hematol; 1986 Nov; 14(10):946-50. PubMed ID: 3533587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of T cells from human bone marrow with monoclonal antibody CT-2 and complement.
    Trigg ME; Billing R; Sondel PM; Dickerman JD; Erickson C; Finlay JL; Bozdech M; Hong R; Padilla-Nash H; Terasaki P
    J Biol Response Mod; 1984 Aug; 3(4):406-12. PubMed ID: 6384432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased incidence of EBV-associated lymphoproliferative disorders after allogeneic stem cell transplantation from matched unrelated donors due to a change of T cell depletion technique.
    Meijer E; Slaper-Cortenbach IC; Thijsen SF; Dekker AW; Verdonck LF
    Bone Marrow Transplant; 2002 Feb; 29(4):335-9. PubMed ID: 11896431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New technology for the depletion of T cells from soybean lectin agglutinated, HLA-matched bone marrow grafts for leukemia: initial laboratory and clinical results.
    Collins NH; Carabasi MH; Bleau S; Jagiello C; Young JW; Castro-Malaspina H; Flomenberg N; Papadopoulos EB; Emanuel D; Gillio A
    Prog Clin Biol Res; 1992; 377():427-39. PubMed ID: 1438441
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell depletion of bone marrow transplants: assessment of standard immunological methods of quantification.
    Autran B; Beaujean F; Pillier C; Kuentz M; Leblond V; Debré P; Bernard A; Binet JL; Duedari N; Vernant JP
    Exp Hematol; 1987 Dec; 15(11):1121-7. PubMed ID: 3315722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of human bone marrow treated with soybean lectin and sheep erythrocytes: stepwise analysis of cell morphology, phenotype and function.
    Schiff SE; Kurtzberg J; Buckley RH
    Clin Exp Immunol; 1987 Jun; 68(3):685-93. PubMed ID: 3498584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T lymphocyte depletion of human peripheral blood and bone marrow using monoclonal antibodies and magnetic microspheres.
    Gee AP; Lee C; Sleasman JW; Madden M; Ugelstad J; Barrett DJ
    Bone Marrow Transplant; 1987 Aug; 2(2):155-63. PubMed ID: 2901878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell depletion of HLA and haploidentical marrow reduces graft-versus-host disease but it may impair a graft-versus-leukemia effect.
    Henslee PJ; Thompson JS; Romond EH; Doukas MA; Metcalfe M; Marshall ME; MacDonald JS
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2701-6. PubMed ID: 3547948
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of T cell depletion of surgically resected cadaveric marrows by monoclonal antibodies: considerations in HLA-mismatched marrow transplantation.
    Gress RE; Bare C; Lucas PJ; Cassel J; Nakamura H; Moses RD; Quinones RR
    Prog Clin Biol Res; 1990; 333():471-88; discussion 489. PubMed ID: 2308996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation between onset of natural killer E-rosette forming cells and of T3-positive cells following HLA-mismatched T cell depleted bone marrow transplantation.
    De Villartay JP; Le Deist F; Griscelli C; Fischer A
    Clin Exp Immunol; 1987 Feb; 67(2):406-14. PubMed ID: 3301094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.